Page last updated: 2024-08-24

1h-imidazo(4,5-b)pyridine and Psychotic Disorders

1h-imidazo(4,5-b)pyridine has been researched along with Psychotic Disorders in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arrington, K; Dudkin, V; Fillgrove, KL; Garbaccio, RM; Hartingh, TJ; Huszar, SL; Jacobson, MA; Kelly, MJ; Kuo, Y; Layton, ME; Magliaro, BC; O'Brien, JA; Reif, AJ; Rodzinak, K; Tang, C; Uslaner, JM; Wang, C1

Other Studies

1 other study(ies) available for 1h-imidazo(4,5-b)pyridine and Psychotic Disorders

ArticleYear
Discovery of 5-aryl-1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-ones as positive allosteric modulators of metabotropic glutamate subtype-2 (mGlu2) receptors with efficacy in a preclinical model of psychosis.
    Bioorganic & medicinal chemistry letters, 2016, Feb-15, Volume: 26, Issue:4

    Topics: Allosteric Regulation; Animals; Disease Models, Animal; Drug Evaluation, Preclinical; Imidazoles; Locomotion; Protein Binding; Psychotic Disorders; Pyridines; Pyridones; Rats; Receptors, Metabotropic Glutamate; Structure-Activity Relationship

2016